114 related articles for article (PubMed ID: 3260074)
1. Intravenous administration of alpha-1-proteinase inhibitor in patients of PiZ and PiM phenotype. Preliminary report.
Moser KM; Smith RM; Spragg RG; Tisi GM
Am J Med; 1988 Jun; 84(6A):70-4. PubMed ID: 3260074
[TBL] [Abstract][Full Text] [Related]
2. Production and administration to dogs of aerosols of alpha-1-proteinase inhibitor.
Smith RM; Spragg RG
Am J Med; 1988 Jun; 84(6A):48-51. PubMed ID: 3260073
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary penetration of alpha 1-proteinase inhibitor administered parenterally to dogs.
Smith RM; Spragg RG; Moser KM; Cochrane CG; McCarren JP
Am Rev Respir Dis; 1987 Dec; 136(6):1391-6. PubMed ID: 3120632
[TBL] [Abstract][Full Text] [Related]
4. Replacement therapy for alpha-1-protease inhibitor deficiency in PiZ subjects with chronic obstructive lung disease.
Schmidt EW; Rasche B; Ulmer WT; Konietzko N; Becker M; Fallise JP; Lorenz J; Ferlinz R
Am J Med; 1988 Jun; 84(6A):63-9. PubMed ID: 3289388
[TBL] [Abstract][Full Text] [Related]
5. Preclinical evaluation of alpha-1-proteinase inhibitor. Pharmacokinetics and safety studies.
Fournel MA; Newgren JO; Betancourt CM; Irwin RG
Am J Med; 1988 Jun; 84(6A):43-7. PubMed ID: 3260072
[TBL] [Abstract][Full Text] [Related]
6. Natural history of alpha-1-protease inhibitor deficiency.
Hutchison DC
Am J Med; 1988 Jun; 84(6A):3-12. PubMed ID: 3289386
[TBL] [Abstract][Full Text] [Related]
7. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
Smith RM; Traber LD; Traber DL; Spragg RG
J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
[TBL] [Abstract][Full Text] [Related]
9. Biochemical reaction of alpha 1 antitrypsin during the substitution therapy of patients with homozygote PI-ZZ deficit.
Gillissen A; Schmidt EW; Rasche B; Ulmer WT
Klin Wochenschr; 1989 Mar; 67(6):328-35. PubMed ID: 2785232
[TBL] [Abstract][Full Text] [Related]
10. [A study of antielastase activity in the development of pulmonary emphysema in a family with alpha 1-antitrypsin deficiency].
Kishi F; Kakinoki A
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):565-70. PubMed ID: 2615095
[TBL] [Abstract][Full Text] [Related]
11. Biochemical efficacy and safety of a new, ready-to-use, liquid alpha-1-proteinase inhibitor, GLASSIA (alpha1-proteinase inhibitor (human), intravenous).
Sandhaus RA; Stocks J; Rouhani FN; Brantly M; Strauss P
COPD; 2014 Feb; 11(1):17-25. PubMed ID: 23822603
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR;
Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
[TBL] [Abstract][Full Text] [Related]
14. Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.
Gadek JE; Klein HG; Holland PV; Crystal RG
J Clin Invest; 1981 Nov; 68(5):1158-65. PubMed ID: 7028785
[TBL] [Abstract][Full Text] [Related]
15. Pallid mice with genetic emphysema. Neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population.
de Santi MM; Martorana PA; Cavarra E; Lungarella G
Lab Invest; 1995 Jul; 73(1):40-7. PubMed ID: 7603039
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
[TBL] [Abstract][Full Text] [Related]
17. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
Horowitz ID; Schulman ES
Am Fam Physician; 1989 Sep; 40(3):223-8. PubMed ID: 2672752
[TBL] [Abstract][Full Text] [Related]
18. [Functional activity of the alpha1-proteinase inhibitor in serum and bronchoalveolar lavage fluid in congenital lung emphysema].
Trefz G; Heck B; Schulz V; Ebert W
Pneumologie; 1989 Aug; 43(8):446-51. PubMed ID: 2788886
[TBL] [Abstract][Full Text] [Related]
19. Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer.
Marchandise FX; Mathieu B; Francis C; Sibille Y
Eur Respir J; 1989 Jul; 2(7):623-9. PubMed ID: 2476329
[TBL] [Abstract][Full Text] [Related]
20. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
